
Meishi Pharma Services Private Limited
About Meishi Pharma Services Private Limited
Data last updated:
Meishi Pharma Services Private Limited is a foreign private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 October 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2022FTC392636. Its GSTIN is 27AAQCM3026P1ZV (Maharashtra). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Cr and a paid-up capital of ₹9.13 Lakh. It is led by directors including Ee Ling Chan and Petar Vazharov.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.29 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹3.66 Cr (net margin -18.1%) and EBITDA of -₹29.04 Lakh (EBITDA margin -1.4%).
The company has about 106 employees on its provident fund (EPFO) records.
Company details
Contact details
Meishi Pharma Services Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressB Wing 44th Floor 4404, Plot No.46 N C Kelkar Marg Opp Shivsena Bhavan Dadar (W), Mumbai, Maharashtra, India – 400028
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Meishi Pharma Services Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Meishi Pharma Services is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Meishi Pharma Services Private Limited, buy the company report.
Financials of Meishi Pharma Services Private Limited
FY 2025 filings availableMeishi Pharma Services Private Limited reported revenue of ₹20.29 Cr (up 886% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 886% in the latest year. EBITDA rose 87% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹29.04 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹3.66 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.4% | ||
| Net Profit Margin | -18.1% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Meishi Pharma Services Private Limited, buy the company report.
Board of directors of Meishi Pharma Services Private Limited
Meishi Pharma Services has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ee Ling Chan | Director | 06 Sep 2023 | 3 Years 2 Months | Current |
| Petar Vazharov | Director | 26 Oct 2022 | 4 Years 0 Months | Current |
| Mohit Suhas Patwardhan | Director | 26 Oct 2022 | 4 Years 0 Months | Current |
| Vamsi Kiran Kosaraju | Director | 09 Sep 2025 | 1 Years 2 Months | Current |
Auditor
Meishi Pharma Services Private Limited is audited by Amarnath Kamath & associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Amarnath Kamath & associates | FY 2023 | 219265 |
Shareholding
The shareholding of Meishi Pharma Services Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Meishi Pharma Services Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meishi Pharma Services Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meishi Pharma Services Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Meishi Pharma Services Private Limited has a workforce of 106 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 106 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 |
To see the full employee and EPFO history of Meishi Pharma Services Private Limited, buy the company report.
GST
Meishi Pharma Services has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAQCM3026P1ZV | Maharashtra | Active | 02 Mar 2023 |
| 36AAQCM3026P1ZW | Telangana | Active | 27 Jul 2023 |
To see the full GST registrations and return filing status of Meishi Pharma Services Private Limited, buy the company report.
Recent activity
Meishi Pharma Services Private Limited has 6 board changes on record since 2022: 4 appointments and 2 cessations. The latest: Vamsi Kiran Kosaraju ceased to be Additional Director on 29 Sep 2025.
Frequently asked questions
Meishi Pharma Services is an active foreign private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 October 2022 (4+ years old) and is registered under CIN U24290MH2022FTC392636.
Meishi Pharma Services has 4 current directors:
- Ee Ling Chan - Director
- Petar Vazharov - Director
- Mohit Suhas Patwardhan - Director
- Vamsi Kiran Kosaraju - Director
The latest financial statements of Meishi Pharma Services on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Meishi Pharma Services is 27AAQCM3026P1ZV, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 36AAQCM3026P1ZW (Telangana).
The CIN (Corporate Identification Number) of Meishi Pharma Services is U24290MH2022FTC392636. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meishi Pharma Services was incorporated on 26 October 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
Vamsi Kiran Kosaraju ceased to be Additional Director on 29 Sep 2025. Vamsi Kiran Kosaraju was appointed as Director on 09 Sep 2025. Ee Ling Chan ceased to be Additional Director on 29 Sep 2023. Meishi Pharma Services has 6 board changes on record in total.
The registered office of Meishi Pharma Services is at B Wing 44th Floor 4404, Plot No.46 N C Kelkar Marg Opp Shivsena Bhavan Dadar W, Mumbai, Maharashtra, India – 400028.
Meishi Pharma Services operates in the pharma industry, in the drug formulation and development segment.
Meishi Pharma Services can be reached at its registered office: B Wing 44th Floor 4404, Plot No.46 N C Kelkar Marg Opp Shivsena Bhavan Dadar W, Mumbai, Maharashtra, India – 400028.

